Jared Beyersdorf

Jared Beyersdorf

Auto-generated profile, based on publicly available information

Jared Beyersdorf

Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2021 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
EBEmmeline L. Blanchard
Emmeline L. Blanchard
DVDaryll Vanover
Daryll Vanover
SBSwapnil Bawage
Swapnil Bawage
PTPooja Tiwari
Pooja Tiwari
LRLaura Rotolo
Laura Rotolo
PSPhilip J. Santangelo
Philip J. Santangelo

1 April 2019 in Nature Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
KLKevin E. Lindsay
Kevin E. Lindsay
SBSushma M. Bhosle
Sushma M. Bhosle
CZChiara Zurla
Chiara Zurla
JBJared Beyersdorf
Jared Beyersdorf
KRKenneth A. Rogers
Kenneth A. Rogers
PSPhilip J. Santangelo
Philip J. Santangelo

28 November 2022 in Nature Materials
Verified
Journal Article
Open access
PDF file
LRLaura Rotolo
Laura Rotolo
DVDaryll Vanover
Daryll Vanover
NBNicholas C. Bruno
Nicholas C. Bruno
HPHannah E. Peck
Hannah E. Peck
CZChiara Zurla
Chiara Zurla
PSPhilip J. Santangelo
Philip J. Santangelo
Messenger RNA has now been used to vaccinate millions of people. However, the diversity of pulmonary pathologies, including infections, genetic disorders, asthma and others, reveals the lung as an important organ to directly target for future RNA therapeutics and preventatives. Here we report the screening of 166 polymeric nanoparticle formulations for functional delivery to the lungs, obtained from a combinatorial synthesis approach combined with a low-dead-volume nose-only inhalation system for mice. We identify P76, a poly-β-amino-thio-ester polymer, that exhibits increased expression over formulations lacking the thiol component, delivery to different animal species with varying RNA cargos and low toxicity. P76 allows for dose sparing when delivering an mRNA-expressed Cas13a-mediated treatment in a SARS-CoV-2 challenge model, resulting in similar efficacy to a 20-fold higher dose of a neutralizing antibody. Overall, the combinatorial synthesis approach allowed for the discovery of promising polymeric formulations for future RNA pharmaceutical development for the lungs.

7 February 2022 in Nature Nanotechnology
Verified
Journal Article
Closed access
PDF file
MHMarine Z. C. Hatit
Marine Z. C. Hatit
MLMelissa P. Lokugamage
Melissa P. Lokugamage
CDCurtis N. Dobrowolski
Curtis N. Dobrowolski
KPKalina Paunovska
Kalina Paunovska
HNHuanzhen Ni
Huanzhen Ni
JDJames E. Dahlman
James E. Dahlman

2 May 2024 in Nature Biomedical Engineering
Verified
Journal Article
Open access
PDF file
DWDavid W. Wolfson
David W. Wolfson
NKNam Kyun Kim
Nam Kyun Kim
KLKi Hong Lee
Ki Hong Lee
JBJared P. Beyersdorf
Jared P. Beyersdorf
JLJonathan J. Langberg
Jonathan J. Langberg
HCHee Cheol Cho
Hee Cheol Cho
The adenovirus-mediated somatic transfer of the embryonic T-box transcription factor 18 (TBX18) gene can convert chamber cardiomyocytes into induced pacemaker cells. However, the translation of therapeutic TBX18-induced cardiac pacing faces safety challenges. Here we show that the myocardial expression of synthetic TBX18 mRNA in animals generates de novo pacing and limits innate and inflammatory immune responses. In rats, intramyocardially injected mRNA remained localized, whereas direct myocardial injection of an adenovirus carrying a reporter gene resulted in diffuse expression and in substantial spillover to the liver, spleen and lungs. Transient expression of TBX18 mRNA in rats led to de novo automaticity and pacemaker properties and, compared with the injection of adenovirus, to substantial reductions in the expression of inflammatory genes and in activated macrophage populations. In rodent and clinically relevant porcine models of complete heart block, intramyocardially injected TBX18 mRNA provided rate-adaptive cardiac pacing for one month that strongly correlated with the animal’s sinus rhythm and physical activity. TBX18 mRNA may aid the development of biological pacemakers.

1 October 2015 in Journal of Chromatography A
Verified
Journal Article
Closed access
RMRyan Matsuda
Ryan Matsuda
DJDonald Jobe
Donald Jobe
JBJared Beyersdorf
Jared Beyersdorf
DHDavid Hage
David Hage